212 related articles for article (PubMed ID: 10929953)
1. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Eloranta ML; Heinonen S; Kirkinen P
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
[TBL] [Abstract][Full Text] [Related]
2. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
3. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
4. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
5. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
6. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
8. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum second trimester AFP and hCG in pregnancies with placenta previa.
Heikkilä A; Heinonen S; Kirkinen P
Prenat Diagn; 2000 Feb; 20(2):100-2. PubMed ID: 10694682
[TBL] [Abstract][Full Text] [Related]
10. Maternal midtrimester free beta-HCG and AFP serum levels in spontaneous singleton pregnancies complicated by gestational diabetes mellitus, pregnancy-induced hypertension or obstetric cholestasis.
Räty R; Anttila L; Virtanen A; Koskinen P; Laitinen P; Mörsky P; Tiitinen A; Martikainen H; Ekblad U
Prenat Diagn; 2003 Dec; 23(13):1045-8. PubMed ID: 14691989
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
12. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
13. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
14. Dependence of maternal serum [AFP]/[hCG] median ratios on age of gestation: comparison of trisomy 21 to euploid pregnancies.
Marcus-Braun N; Birk O; Manor E; Segal D; Harari G; Toma I; Shalev S; Borochowitz ZU; Yaron Y; Sharony R; Itzhaky D; Shtoyerman R; Appelman Z; Braun G
Prenat Diagn; 2009 Dec; 29(12):1130-4. PubMed ID: 19777489
[TBL] [Abstract][Full Text] [Related]
15. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
16. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
17. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
[TBL] [Abstract][Full Text] [Related]
18. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
19. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Frishman GN; Canick JA; Hogan JW; Hackett RJ; Kellner LH; Saller DN
Obstet Gynecol; 1997 Jul; 90(1):98-101. PubMed ID: 9207822
[TBL] [Abstract][Full Text] [Related]
20. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]